Status:

COMPLETED

Cardiovascular Effects of Rapidly Declining Plasma Glucose in Patients With Type 1 Diabetes

Lead Sponsor:

Steno Diabetes Center Copenhagen

Collaborating Sponsors:

University Hospital, Gentofte, Copenhagen

Rigshospitalet, Denmark

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Type 1 diabetes (T1D) is an autoimmune metabolic disease characterised by impaired lack of endogenous insulin causing elevated plasma glucose levels and increased risk of microvascular and macrovascul...

Eligibility Criteria

Inclusion

  • Inclusion criteria - chronic hyperglycaemia cohort
  • Informed and written consent
  • Type 1 diabetes
  • Age ≥18 years
  • C-peptide negative (\<0.2 nmol/l)
  • Insulin treatment for ≥1 year
  • HbA1C ≥63 mmol/mol
  • Inclusion criteria - well-controlled cohort
  • Informed and written consent
  • Type 1 diabetes
  • Age ≥18 years
  • C-peptide negative (\<0.2nmol/l)
  • Insulin treatment for ≥1 year
  • HbA1C ≤53 mmol/mol
  • Exclusion criteria - both cohorts
  • Arrhythmia diagnosed prior to or at the time of the screening visit
  • ECG with left or right bundle branch block diagnosed prior to the screening visit.
  • Implantable cardioverter defibrillator or pacemaker at the time of inclusion
  • Heart failure diagnosed prior to the screening visit (left ventricular ejection fraction \< 45%)
  • Structural heart disease (Wolf-Parkinson-White syndrome, congenital heart disease, severe valve disease)
  • Thyroid dysfunction (except for well-regulated myxoedema)
  • Anaemia (male: haemoglobin \<8.0 mmol/l; female: haemoglobin \<7.0 mmol/l)
  • Treatment with anticoagulant or antiplatelet treatment
  • Bleeding disorder diagnosed prior to the screening visit
  • Withdrawal criteria
  • • The participants may withdraw at will at any time

Exclusion

    Key Trial Info

    Start Date :

    June 1 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2023

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT04800536

    Start Date

    June 1 2021

    End Date

    April 1 2023

    Last Update

    April 12 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Steno Diabetes Center Copenhagen - Gentofte Hospital

    Copenhagen, Denmark, 2900